Immunity and Type 1 Diabetes Test

Immunity and Type 1 Diabetes 

 

Aim

  • To lead on clinical trials in diabetes immunotherapy across the UK

 

Objectives

  • lead on clinical trials and staff training in diabetes immunotherapy across 15 centres in the UK (“Type 1 Diabetes UK Immunotherapy Consortium”)
  • combine with the DRN England ADDRESS-2 research network identifying subjects with newly-diagnosed type 1 diabetes from 122 centres across the UK.